Anzeige
Mehr »
Login
Freitag, 26.04.2024 Börsentäglich über 12.000 News von 687 internationalen Medien
Wie die Revolution der sauberen Energie eine solide Investitionsmöglichkeit bieten könnte
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
119 Leser
Artikel bewerten:
(0)

Research and Markets - Global Gynecology Surgical Devices Market to Grow at a CAGR of 3.17% by 2021 - Key Vendors are CooperSurgical, Hologic, Boston Scientific, Intuitive Surgical, Karl Storz & Thermo Fisher Scientific

DUBLIN, Apr. 25, 2017 /PRNewswire/ --

Research and Markets has announced the addition of the "Global Gynecology Surgical Devices Market 2017-2021" report to their offering.

Research and Markets Logo

The global gynecology surgical devices market to grow at a CAGR of 3.17% during the period 2017-2021.

The report, Global Gynecology Surgical Devices Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the Key vendors operating in this market.

One trend in market is increasing adoption of robotic navigation technologies for laparoscopy. Technological innovations in ablation procedures have led to high accuracy with advanced needle placement technology to provide better support for both patients and surgeons. Robotic technology helps enhance surgeon's skills and reduces variability. It also helps in reduction of incision and improvement of recovery time.

According to the report, one driver in market is growing hospital investments in gynecology surgical instruments. Endoscopy is the most common surgical technique used for the treatment of gynecological disorders. Different endoscopy devices are used to enhance the success rate of these procedures. The growth in older population along with the rising incidence of cervical cancer, ovarian cancer, and other gynecological disorders contribute to the high consumption of gynecological surgical devices such as endoscopy ablation systems and endometrial ablation systems. The rising incidence of gynecological disorders and higher success rate of these devices are driving the hospital investment in endoscopy instruments. For instance, in November 2016, Hologic launched the advanced NovaSure global endometrial ablation system for enhancing the treatment of abnormal uterine bleeding. The product was launched in Europe, Canada, and Australia with CE mark approval. Hospital investments in these devices in APAC and EMEA increase patient comfort and operational success rate.

Key vendors

  • CooperSurgical
  • Hologic
  • Boston Scientific
  • Intuitive Surgical
  • Karl Storz
  • Thermo Fisher Scientific

Other Prominent Vendors

  • ACTEON Group
  • BD
  • Carl Zeiss Meditec
  • CONMED
  • Endotherapeutics
  • Ethicon
  • MedGyn Products
  • Medtronic
  • Others

Key Topics Covered:

  1. Executive summary
  2. Scope of the report
  3. Research Methodology
  4. Introduction
  5. Key market highlights
  6. Market landscape
  7. Market segmentation by end-user
  8. Geographical segmentation
  9. Market drivers
  10. Market challenges
  11. Market trends
  12. Vendor landscape
  13. Key vendor analysis
  14. Appendix

For more information about this report visit http://www.researchandmarkets.com/research/8crq75/global_gynecology

Media Contact:

Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2017 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.